176 related articles for article (PubMed ID: 26553387)
21. MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide.
Okishiro M; Kim SJ; Tsunashima R; Nakayama T; Shimazu K; Shimomura A; Maruyama N; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Apr; 132(3):947-53. PubMed ID: 21706156
[TBL] [Abstract][Full Text] [Related]
22. Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.
Jamshidi M; Schmidt MK; Dörk T; Garcia-Closas M; Heikkinen T; Cornelissen S; van den Broek AJ; Schürmann P; Meyer A; Park-Simon TW; Figueroa J; Sherman M; Lissowska J; Keong GT; Irwanto A; Laakso M; Hautaniemi S; Aittomäki K; Blomqvist C; Liu J; Nevanlinna H
Int J Cancer; 2013 May; 132(9):2044-55. PubMed ID: 23034890
[TBL] [Abstract][Full Text] [Related]
23. Effects of p53 codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population.
Moradi MT; Salehi Z; Aminian K; Yazdanbod A
Asian Pac J Cancer Prev; 2014; 15(17):7413-7. PubMed ID: 25227851
[TBL] [Abstract][Full Text] [Related]
24. Gene-to-gene interactions and the association of TP53, XRCC1, TNFα, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females.
Isakova JT; Vinnikov D; Kipen VN; Talaibekova ET; Aldashev AA; Aldasheva NM; Makieva KB; Semetei Kyzy A; Bukuev NM; Tilekov EA; Shaimbetov BO; Kudaibergenova IO
Breast Cancer; 2020 Sep; 27(5):938-946. PubMed ID: 32297247
[TBL] [Abstract][Full Text] [Related]
25. MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia.
Ebid GT; Sedhom IA; El-Gammal MM; Moneer MM
Asian Pac J Cancer Prev; 2012; 13(9):4315-20. PubMed ID: 23167335
[TBL] [Abstract][Full Text] [Related]
26. Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.
Yoneda T; Kuboyama A; Kato K; Ohgami T; Okamoto K; Saito T; Wake N
Oncol Rep; 2013 Jul; 30(1):25-34. PubMed ID: 23624782
[TBL] [Abstract][Full Text] [Related]
27. TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
Abderrahmane R; Louhibi L; Moghtit FZ; Boubekeur A; Benseddik K; Boudjema A; Benrrahal F; Aberkane M; Fodil M; Saidi-Mehtar N
Pathol Oncol Res; 2015 Jul; 21(3):629-35. PubMed ID: 25537146
[TBL] [Abstract][Full Text] [Related]
28. Evidence for an epistatic effect between TP53 R72P and MDM2 T309G SNPs in HIV infection: a cross-sectional study in women from South Brazil.
Hartwig FP; Entiauspe LG; Nunes EM; Rodrigues FM; Collares T; Seixas FK; da Silveira MF
PLoS One; 2014; 9(2):e89489. PubMed ID: 24586820
[TBL] [Abstract][Full Text] [Related]
29. The p53 G72C and MDM2 T309G single nucleotide polymorphisms in patients with Wegener's granulomatosis.
Assmann G; Wieczorek S; Wibisono D; Roemer K; Arning L; Voswinkel J
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S72-5. PubMed ID: 18799058
[TBL] [Abstract][Full Text] [Related]
30. [Association of polymorphic markers Arg72Pro of TP53 and T309g of MDM2 genes with non small cell lung cancer in Russians of Moscow region].
Loginov VI; Atkarskaia MV; Burdennyĭ AM; Zavarykina TM; Kazubskaia TP; Nosikov VV; Braga ÉA; Zhizhina GP
Mol Biol (Mosk); 2014; 48(1):62-8. PubMed ID: 25842826
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
32. Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.
Onel KB; Huo D; Hastings D; Fryer-Biggs J; Crow MK; Onel K
Lupus; 2009 Jan; 18(1):61-6. PubMed ID: 19074170
[TBL] [Abstract][Full Text] [Related]
33. Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese.
Xu B; Xu Z; Cheng G; Min ZC; Mi Y; Zhang ZZ; Tao J; Li PC; Wang ML; Tang JL; Zhang ZD; Zhang W; Wu HF; Feng NH; Hua LX
Cancer Genet Cytogenet; 2010 Oct; 202(2):76-81. PubMed ID: 20875869
[TBL] [Abstract][Full Text] [Related]
34. Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer.
Yang M; Guo Y; Zhang X; Miao X; Tan W; Sun T; Zhao D; Yu D; Liu J; Lin D
Carcinogenesis; 2007 Sep; 28(9):1996-2001. PubMed ID: 17638920
[TBL] [Abstract][Full Text] [Related]
35. p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
Cescon DW; Bradbury PA; Asomaning K; Hopkins J; Zhai R; Zhou W; Wang Z; Kulke M; Su L; Ma C; Xu W; Marshall AL; Heist RS; Wain JC; Lynch TJ; Christiani DC; Liu G
Clin Cancer Res; 2009 May; 15(9):3103-9. PubMed ID: 19383811
[TBL] [Abstract][Full Text] [Related]
36. Impact of TP53 codon 72 and MDM2 promoter 309 allelic dosage in a Moroccan population with hepatocellular carcinoma.
Ezzikouri S; Essaid El Feydi A; Afifi R; Benazzouz M; Hassar M; Pineau P; Benjelloun S
Int J Biol Markers; 2011; 26(4):229-33. PubMed ID: 22180176
[TBL] [Abstract][Full Text] [Related]
37. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
[TBL] [Abstract][Full Text] [Related]
38. p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma.
Liu G; Cescon DW; Zhai R; Zhou W; Kulke MH; Ma C; Xu W; Su L; Asomaning K; Heist RS; Wain JC; Lynch TJ; Christiani DC
Dis Esophagus; 2010 Jan; 23(1):36-9. PubMed ID: 19302219
[TBL] [Abstract][Full Text] [Related]
39. TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
Joshi AM; Budhathoki S; Ohnaka K; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y
Jpn J Clin Oncol; 2011 Feb; 41(2):232-8. PubMed ID: 21051533
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population.
Xiao M; Zhang L; Zhu X; Huang J; Jiang H; Hu S; Liu Y
BMC Cancer; 2010 Apr; 10():147. PubMed ID: 20398418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
